(4R,5S,6S,7S,9R,11E,13E,15R,16R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,7,9,13-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (4R,5S,6S,7S,9R,11E,13E,15R,16R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,7,9,13-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione
• 化学式: C₃₈H₆₅NO₁₂
• 分子量: 727.9
• InChiKey: MMHPQRIORHAXGA-PRAYNDSJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  51
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.84
• 拓扑面积：
  163
• 氢给体数：
  3
• 氢受体数：
  13

反应信息

• 作为产物：
  描述：

  (4R,5S,6S,7S,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-4-(dimethylamino)-3-hydroxy-5-iodo-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,7,9,13-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione 、 三正丁基氢锡 生成 (4R,5S,6S,7S,9R,11E,13E,15R,16R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,7,9,13-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione
  参考文献：
  名称：

  FUJIWARA, TATSURO;WATANABE, HIDEYUKI;KOGAMI, YUJI;SHIRITANI, YOSHINORI;SA+, J. ANTIBIOTICS, 42,(1989) N, C. 903-912

  摘要：

  DOI：

文献信息

• FUJIWARA, TATSURO;WATANABE, HIDEYUKI;KOGAMI, YUJI;SHIRITANI, YOSHINORI;SA+, J. ANTIBIOTICS, 42,(1989) N, C. 903-912
  作者：FUJIWARA, TATSURO、WATANABE, HIDEYUKI、KOGAMI, YUJI、SHIRITANI, YOSHINORI、SA+

  DOI：——

  日期：——